ATE231124T1 - Azetidinonderivate zur behandlung von hcmv entzündungen - Google Patents

Azetidinonderivate zur behandlung von hcmv entzündungen

Info

Publication number
ATE231124T1
ATE231124T1 AT98947257T AT98947257T ATE231124T1 AT E231124 T1 ATE231124 T1 AT E231124T1 AT 98947257 T AT98947257 T AT 98947257T AT 98947257 T AT98947257 T AT 98947257T AT E231124 T1 ATE231124 T1 AT E231124T1
Authority
AT
Austria
Prior art keywords
lower alkyl
phenyl
het
optionally substituted
alkyl
Prior art date
Application number
AT98947257T
Other languages
German (de)
English (en)
Inventor
Christiane Yoakim
Catherine Chabot
Robert Deziel
Stephen Kawai
Willian W Ogilvie
Jeffrey O'meara
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of ATE231124T1 publication Critical patent/ATE231124T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT98947257T 1997-10-07 1998-10-06 Azetidinonderivate zur behandlung von hcmv entzündungen ATE231124T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6154897P 1997-10-07 1997-10-07
PCT/CA1998/000954 WO1999018073A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (1)

Publication Number Publication Date
ATE231124T1 true ATE231124T1 (de) 2003-02-15

Family

ID=22036473

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98947257T ATE231124T1 (de) 1997-10-07 1998-10-06 Azetidinonderivate zur behandlung von hcmv entzündungen

Country Status (10)

Country Link
US (1) US6211170B1 (enExample)
EP (1) EP1023265B1 (enExample)
JP (1) JP2001519330A (enExample)
AT (1) ATE231124T1 (enExample)
AU (1) AU9426198A (enExample)
CA (1) CA2301967C (enExample)
DE (1) DE69810800T2 (enExample)
DK (1) DK1023265T3 (enExample)
ES (1) ES2187064T3 (enExample)
WO (1) WO1999018073A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541357B2 (en) 2004-07-15 2009-06-02 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0608899D0 (en) * 2006-05-05 2006-06-14 Leuven K U Res & Dev Novel viral replication inhibitors
WO2009045382A1 (en) * 2007-10-04 2009-04-09 Merck & Co., Inc. Substituted aryl sulfone derivatives as calcium channel blockers
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
CA2760837C (en) * 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
JP5739415B2 (ja) * 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
ES2446971T3 (es) * 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
US9216180B2 (en) 2012-10-02 2015-12-22 New York University Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
TWI838401B (zh) 2018-09-12 2024-04-11 瑞士商諾華公司 抗病毒性吡啶并吡𠯤二酮化合物
TWI867053B (zh) 2019-09-26 2024-12-21 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
EP0377549B1 (en) 1989-01-03 1998-12-09 Marcos Y. Kleinerman Remote measurement of physical variables with fiber optic systems
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) * 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
EP0804930A1 (en) * 1994-03-23 1997-11-05 Tokyo Tanabe Company Limited Novel remedy for respiratory-tract viral disease

Also Published As

Publication number Publication date
CA2301967A1 (en) 1999-04-15
DE69810800T2 (de) 2003-09-18
DK1023265T3 (da) 2003-02-24
US6211170B1 (en) 2001-04-03
EP1023265A1 (en) 2000-08-02
AU9426198A (en) 1999-04-27
WO1999018073A1 (en) 1999-04-15
CA2301967C (en) 2005-05-17
DE69810800D1 (de) 2003-02-20
JP2001519330A (ja) 2001-10-23
ES2187064T3 (es) 2003-05-16
EP1023265B1 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
ATE222894T1 (de) Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
NO931529D0 (no) Cykliske fruktopyranosesulfitter og -sulfater med antikonvulsiv effekt
MY104652A (en) A spiro compound
DE60005504D1 (de) Chinolinderivate als mek enzym-inhibitoren
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
PT849269E (pt) Vinil-pirrolidina cefalosporinas com substituintes basicos
ATE231124T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
FI925871A0 (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
DE69434720D1 (de) Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom
HUP0000894A2 (hu) Szubsztituált (1,3-bisz(ciklohexilmetil)-1,2,3,6-tetrahidro-2,6-dioxo-9H-purin-8-il)fenil-származékok és eljárás előállításukra
ATE156128T1 (de) Substituierte harnstoffe, herstellung und verwendung
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
DE69502587D1 (de) 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
DK1021404T3 (da) Azetidinonderivater til behandling af HCMV-infektioner
MX9606531A (es) Compuestos farmaceuticos.
ATE250594T1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
NZ336368A (en) Substituted pyrazole-3-yl benzazoles and their use as herbicides
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
MX9708422A (es) Esteres de carbapenemas.
NZ336876A (en) Process for preparation of 4-H-4-oxo-quinolizine-3-carboxylic acid derivatives
CO5261568A1 (es) Oxazolidinonas derivadas de sultamas o sultonas
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1023265

Country of ref document: EP